ISSN 2500-2236
DOI-prefix: 10.18527/2500-2236

Search


Volume 5, Number 1, 2018
... The development of a new medicine is a process that requires enormous time and tremendous financing. It takes 10-15 years from the discovery of an active compound to the launch of its production ...
Authors: Dmitri V. Debabov, Maria D. Debabova
Том 4, номер 1, 2017
... antibiotics are described. Examples of newantibiotics development active against the drug resistant bacteria are presented. ...
Authors: Александр Живич
Volume 4, Number 1, 2017
... these antibiotics are described. Examples of new antibiotics development active against the drug resistant bacteria are presented.  ...
Authors: Alexander Zhivich
Том 5, номер 1, 2018
... The development of a new medicine is a process that requires enormous time and tremendous financing. It takes 10-15 years from the discovery of an active compound to the launch of its production ...
Authors: Д. В. Дебабов, М. Д. Дебабова
Volume 2, Number 1, 2015
... Development of the cell-ELISA test for the subtype identification of circulating influenza A(H1) and A(H3) viruses ...
Authors: Vera Krivitskaya, Evgeniy Sorokin, Tatyana Tsareva, Ekaterina Petrova, Nadezhda Konovalova, Maria Pisareva, Zhanna Buzitskaya, Tatyana Smirnova, Anna Sominina
Volume 3, Number 1, 2016
... Development of the A/H6N1 influenza vaccine candidate based on A/Leningrad/134/17/57 (H2N2) master donor virus and the genome composition analysis using high resolution melting (HRM) ...
Authors: Yulia A. Desheva, Tatiana A. Smolonogina, Galina O. Landgraf, Larisa G. Rudenko
Volume 3, Number 1, 2016
... This research project was supported by the Committee of the Ministry of Science and Education of the Republic of Kazakhstan as a contribution to the project “The development of highly ...
Authors: Kaissar Tabynov
Volume 2, Number 1, 2015
... The system of genetic control of innate immune responses to influenza infection and gene function allows for the development of systemic treatment of influenza with a focus on the phenotype of ...
Authors: O. I. Kiselev, A. B. Komissarov, O.S.Konshina, M.N.Dmitrieva, E.G.Deyeva, T.V.Sologub, V.I.Pokrovskiy
Volume 5, Number 1, 2018
... Every person over the course of their lifetime is repeatedly infected by a variety of respiratory viruses that represent risk factors for the development of bacterial complications. The most ...
Authors: Andrej Egorov
Том 2, номер 1, 2015
... The system of genetic control of innate immune responses to influenza infection and gene function allows for the development of systemic treatment of influenza with a focus on the phenotype ...
Authors: О.И. Киселев, А.Б. Комиссаров, О.С. Коншина, М.Н. Дмитриева, Э.Г. Деева, Т.В. Сологуб, В.И. Покровский
Том 4, номер 1, 2017
... . The antiviral drug triazavirine is licensed in Russia for the treatment and prophylaxis of acute respiratory infections, including influenza A and B viruses. In the present study, we investigated the ...
Authors: И. А. Ленева, И. Н. Фалинскова, Н. Р. Махмудова, Е. А. Глубокова, Н. П. Карташова, Е. И. Леонова, Н. А. Михайлова, И. В. Шестакова
Volume 5, Number 1, 2018
... , 19]. Inoculation of intact plants was carried out at the stage of development of R1-R2 (6-8 pairs of leaves, the beginning of budding) in triplicates [18 ...
Authors: Maria M. Gomzhina, Philipp B. Gannibal
Volume 4, Number 1, 2017
... ). Bacteria were propagated on tryptic soy agar. Assessment of drug efficacy in mouse models Female BALB/c mice that were obtained from the Scientific Center of ...
Authors: Irina A. Leneva, Irina N. Falynskova, Nailya R. Makhmudova, Ekaterina A. Glubokova, Nadezhda P. Kartashova, Eugenia I. Leonova, Natalya A. Mikhailova, Irina V. Shestakova
Том 5, номер 1, 2018
... losses in the poultry industry. The development of an effective and safe vaccine for the broad protection of poultry from H5N1 HPAIVs remains an important goal. Prevention of the virus transmission ...
Authors: Е. Ю. Боравлева, А. С. Гамбарян
Том 5, номер 1, 2018
... knowledge, this isolate represents the first report of Diaporthe phaseolorum associated with sunflower in the Russian Federation. The development of the stem lesions as a result of the ...
Authors: М. М. Гомжина, Ф. Б. Ганнибал
Volume 5, Number 1, 2018
... losses in the poultry industry. The development of an effective and safe vaccine for the broad protection of poultry from H5N1 HPAIVs remains an important goal. Prevention of the virus transmission ...
Authors: Elizaveta Boravleva, Alexandra Gambaryan
Volume 3, Number 1, 2016
... have a lethal outcome. The first step in the development of infection is the interaction of the influenza virus glycoprotein – hemagglutinin (HA) – with neuraminic acid – the top ...
Authors: Evgeniy V. Sorokin, Tatyana R. Tsareva, Anna A. Sominina, Maria M. Pisareva, Andrey B. Komissarov, Аnna А. Kosheleva
Том 5, номер 1, 2018
... Every person in the course of lifetime is repeatedly infected by a variety of respiratory viruses that represent the risk factors for the development of bacterial complications. The most dangerous ...
Authors: А. Ю. Егоров
Том 3, номер 1, 2016
... important information, concerning the development of a new live modified cold-adapted equine influenza virus vaccine based on the A/HK/Otar/6:2/2010 strain is summarized. We discuss a number of unique ...
Authors: К. К. Табынов
Volume 5, Number 1, 2018
... the conditions for their development on grain substrate are similar. In a previous study, we already showed that there is some symbiotic relationship between aggressive Fusarium fungi and ...
Authors: Aleksandra S. Orina, Olga P. Gavrilova, Tatiana Yu. Gagkaeva